Fear of Cancer Recurrence: A Model Examination of Physical Symptoms, Emotional Distress, and Health Behavior Change.
Journal
Journal of oncology practice
ISSN: 1935-469X
Titre abrégé: J Oncol Pract
Pays: United States
ID NLM: 101261852
Informations de publication
Date de publication:
09 2019
09 2019
Historique:
pubmed:
13
7
2019
medline:
13
8
2020
entrez:
13
7
2019
Statut:
ppublish
Résumé
Fear of cancer recurrence is highly prevalent among adult survivors of cancer. The role of fear of recurrence in the emotional distress of survivors of cancer, as well as health behaviors that may directly affect their health, remains unclear. To advance oncology practice, this study sought to examine the extent to which fear of recurrence stemming from physical symptoms accounts for emotional distress in a large sample of adult survivors of cancer and to extend the model to explain postdiagnosis self-reported health behavior change. In 2016, 258 survivors of cancer at an academic hospital completed a survey of psychosocial needs. Items assessed physical symptoms (checklist), fear of cancer recurrence (Assessment of Survivor Concerns), emotional distress (anxiety and depressed mood), and health behaviors (current alcohol use, physical activity, diet, and sunscreen use, as well as changes after cancer diagnosis) informed by National Comprehensive Cancer Network survivorship guidelines. Indirect effects regression models accounting for relevant covariates (age and treatment history) used 5,000-iteration bootstrapping. Higher fear of cancer recurrence was associated with greater number of physical symptoms ( Fear of cancer recurrence plays a central role in the emotional distress and key health behaviors of survivors of cancer. These findings support fear of cancer recurrence as a potential target for emotional health and health behavior change interventions.
Identifiants
pubmed: 31298966
doi: 10.1200/JOP.18.00787
pmc: PMC6743221
doi:
Types de publication
Journal Article
Research Support, N.I.H., Extramural
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
e787-e797Subventions
Organisme : NCCIH NIH HHS
ID : K24 AT009465
Pays : United States
Organisme : NCI NIH HHS
ID : K24 CA197382
Pays : United States
Organisme : NCCIH NIH HHS
ID : T32 AT000051
Pays : United States
Références
Psychooncology. 2018 Nov;27(11):2546-2558
pubmed: 29744965
J Clin Oncol. 2006 Nov 10;24(32):5125-31
pubmed: 17093274
Arch Intern Med. 1998 Sep 14;158(16):1789-95
pubmed: 9738608
Health Qual Life Outcomes. 2018 Feb 9;16(1):30
pubmed: 29471823
Issues Ment Health Nurs. 1988;9(3):217-38
pubmed: 3198380
Oncology (Williston Park). 2018 Jan 15;32(1):32-8
pubmed: 29447419
J Clin Oncol. 2008 May 1;26(13):2198-204
pubmed: 18445845
J Clin Oncol. 2018 Jan 1;36(1):83-93
pubmed: 29112463
Support Care Cancer. 2017 May;25(5):1401-1407
pubmed: 27966025
Health Qual Life Outcomes. 2007 Mar 13;5:15
pubmed: 17352831
J Cancer Surviv. 2010 Mar;4(1):20-32
pubmed: 19902360
BMJ. 2012 Jan 30;344:e70
pubmed: 22294757
Oncol Nurs Forum. 2004 May;31(3):633-9
pubmed: 15146229
ANS Adv Nurs Sci. 1996 Mar;18(3):59-76
pubmed: 8660013
Support Care Cancer. 2014 Sep;22(9):2489-95
pubmed: 24728586
Image J Nurs Sch. 1990 Winter;22(4):256-62
pubmed: 2292449
Prev Med. 2005 Jun;40(6):702-11
pubmed: 15850868
Addiction. 2008 Jul;103(7):1139-48
pubmed: 18554347
Eur J Cancer Care (Engl). 2013 Jul;22(4):549-58
pubmed: 23517147
Psychooncology. 2015 Apr;24(4):416-23
pubmed: 25156065
Psychooncology. 2016 Dec;25(12):1434-1440
pubmed: 26863926
J Clin Oncol. 2008 Sep 20;26(27):4401-9
pubmed: 18802152
J Clin Oncol. 2006 Aug 1;24(22):3527-34
pubmed: 16822844
Eur J Cancer Care (Engl). 2004 Sep;13(4):328-35
pubmed: 15305900
Psychooncology. 2013 May;22(5):978-86
pubmed: 22674873
J Clin Oncol. 2010 Oct 10;28(29):4410-6
pubmed: 20805458
J Natl Compr Canc Netw. 2017 Sep;15(9):1140-1163
pubmed: 28874599
Nicotine Tob Res. 2014 Feb;16(2):166-73
pubmed: 23999653
Psychooncology. 1997 Jun;6(2):95-105
pubmed: 9205967
J Clin Oncol. 2017 Mar 10;35(8):893-911
pubmed: 27918725
Psychooncology. 2013 Jan;22(1):1-11
pubmed: 22232030
Lancet Oncol. 2006 Feb;7(2):149-56
pubmed: 16455479
J Psychosom Res. 2013 Apr;74(4):354-60
pubmed: 23497839
J Clin Oncol. 2006 Nov 10;24(32):5112-6
pubmed: 17093272
J Clin Oncol. 2005 Dec 1;23(34):8884-93
pubmed: 16314649
Psychooncology. 2017 Oct;26(10):1444-1454
pubmed: 27246348
Psychooncology. 2009 Jun;18(6):580-8
pubmed: 18855944
Health Psychol. 2016 Jan;35(1):1-9
pubmed: 26030308
J Cancer Surviv. 2016 Aug;10(4):692-8
pubmed: 26820142
Cancer. 2000 Feb 1;88(3):674-84
pubmed: 10649263
J Oncol Pract. 2014 May;10(3):162-7
pubmed: 24839274
Psychosomatics. 2011 Sep-Oct;52(5):417-23
pubmed: 21907059
Cancer. 2013 Apr 1;119(7):1420-7
pubmed: 23280005
JAMA Intern Med. 2017 Jul 1;177(7):915-916
pubmed: 28492850
Ann Intern Med. 2000 Sep 19;133(6):479-80
pubmed: 10975969
Clin Psychol Rev. 2017 Aug;56:40-54
pubmed: 28686905
Am J Health Behav. 2003 May-Jun;27(3):246-56
pubmed: 12751621
J Cancer Surviv. 2010 Jun;4(2):87-100
pubmed: 20052559
J Psychosoc Oncol. 2018 Jan-Feb;36(1):64-81
pubmed: 29303476
J Natl Cancer Inst. 2015 Sep 30;107(12):djv275
pubmed: 26424778
Psychooncology. 2018 Mar;27(3):713-724
pubmed: 29247584
Cancer. 2017 Sep 1;123(17):3394-3401
pubmed: 28472548
J Clin Oncol. 2017 Oct 10;35(29):3275-3278
pubmed: 28723231
Psychooncology. 2012 Jun;21(6):571-87
pubmed: 22021099
Image J Nurs Sch. 1988 Winter;20(4):225-32
pubmed: 3203947